m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00533)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
ACIN1
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) [READER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | METTL3 interacts with IGF2BP3 to promote the mRNA stability of Apoptotic chromatin condensation inducer in the nucleus (ACIN1), the overexpression of which induces the aggressiveness of CC cells. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Cervical cancer | ICD-11: 2C77 | ||
Pathway Response | mRNA surveillance pathway | hsa03015 | ||
RNA degradation | hsa03018 | |||
Cell Process | RNA stability | |||
In-vitro Model | SiHa | Cervical squamous cell carcinoma | Homo sapiens | CVCL_0032 |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
End1/E6E7 | Normal | Homo sapiens | CVCL_3684 | |
In-vivo Model | 2 × 106 stably transfected HeLa cells were subcutaneously inoculated into the left flank of mice. | |||
Methyltransferase-like 3 (METTL3) [WRITER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | METTL3 interacts with IGF2BP3 to promote the mRNA stability of Apoptotic chromatin condensation inducer in the nucleus (ACIN1), the overexpression of which induces the aggressiveness of CC cells. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Cervical cancer | ICD-11: 2C77 | ||
Pathway Response | mRNA surveillance pathway | hsa03015 | ||
RNA degradation | hsa03018 | |||
Cell Process | RNA stability | |||
In-vitro Model | SiHa | Cervical squamous cell carcinoma | Homo sapiens | CVCL_0032 |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
End1/E6E7 | Normal | Homo sapiens | CVCL_3684 | |
In-vivo Model | 2 × 106 stably transfected HeLa cells were subcutaneously inoculated into the left flank of mice. | |||
Cervical cancer [ICD-11: 2C77]
In total 2 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | METTL3 interacts with IGF2BP3 to promote the mRNA stability of Apoptotic chromatin condensation inducer in the nucleus (ACIN1), the overexpression of which induces the aggressiveness of CC cells. | |||
Responsed Disease | Cervical cancer [ICD-11: 2C77] | |||
Target Regulator | Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) | READER | ||
Target Regulation | Up regulation | |||
Pathway Response | mRNA surveillance pathway | hsa03015 | ||
RNA degradation | hsa03018 | |||
Cell Process | RNA stability | |||
In-vitro Model | SiHa | Cervical squamous cell carcinoma | Homo sapiens | CVCL_0032 |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
End1/E6E7 | Normal | Homo sapiens | CVCL_3684 | |
In-vivo Model | 2 × 106 stably transfected HeLa cells were subcutaneously inoculated into the left flank of mice. | |||
Experiment 2 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | METTL3 interacts with IGF2BP3 to promote the mRNA stability of Apoptotic chromatin condensation inducer in the nucleus (ACIN1), the overexpression of which induces the aggressiveness of CC cells. | |||
Responsed Disease | Cervical cancer [ICD-11: 2C77] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Up regulation | |||
Pathway Response | mRNA surveillance pathway | hsa03015 | ||
RNA degradation | hsa03018 | |||
Cell Process | RNA stability | |||
In-vitro Model | SiHa | Cervical squamous cell carcinoma | Homo sapiens | CVCL_0032 |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
End1/E6E7 | Normal | Homo sapiens | CVCL_3684 | |
In-vivo Model | 2 × 106 stably transfected HeLa cells were subcutaneously inoculated into the left flank of mice. | |||